The #OncoAlertColloquium 2026 GYN Malignancies🚨 DAY FOUR (ESGO) Presentation by Dr. Nicolò Bizzarri🇮🇹 : Year in Review Surgical #CervicalCancer REGISTER HERE TO WATCH: buff.ly/xwD5G2D Surgical trials for cervical cancer in 2025 focused on de-escalation of surgical radicality.

Awesome 👏🏾 Barbara 👏🏾 Honored to be included in Barbara Segarra’s plenary session @sabcs.bsky.social and proud to work alongside you! @swog.org @oncoalert.bsky.social @oncodaily.bsky.social #bcsm #breastcancer #advocates #oncoalert #clinicaltrials #research #SABCS25

New open-access article in Supportive Care in Cancer: Gaps in care, support, and research among diverse patients with early onset cancers link.springer.com/article/10.1... #SuppOnc

Dr. Guannan Gong shares how an #AI-driven patient-matching system improved ID of eligible patients for #breastcancer trials + increased representation of under-enrolled groups. #SABCS25 @maryamlustberg.bsky.social @sabcs.bsky.social @oncoalert.bsky.social

15 Posts Not to Miss from SABCS 2025, Part 1 @sabcs.bsky.social @drsgraff.bsky.social @ptarantinomd.bsky.social @stage4kelly.bsky.social @maryamlustberg.bsky.social oncodaily.com/not-to-miss/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SABCS #SABCS25 #SABCS2025

@maryamlustberg.bsky.social highlights why patient-reported outcomes (PROs) must be central to oncology drug development and clinical trials at #SABCS25: "Partnering with our patients and patient advocacy organizations is the path forward." @sabcs.bsky.social

@maryamlustberg.bsky.social breaks down key insights on hormone replacement therapy #HRT for #breastcancer survivors at #SABCS25: "We are not the hormone police—our role is to empower patients." @sabcs.bsky.social

Important conversation at #SABCS25 on hormone replacement therapy in breast cancer care with Drs. @lisalarkinmd.bsky.social, Jewel King, Thelma Brown, @maryamlustberg.bsky.social, and Tara Sanft. @theaacr.bsky.social @sabcs.bsky.social

@maryamlustberg.bsky.social highlights the major unmet needs in #menopause care after #breastcancer at #SABCS25. “Our patients have a lot of symptoms and they are not always being addressed — we need to do a lot better.” @sabcs.bsky.social

This afternoon at 2:30pm CST/3:30pm EST #SABCS25, @maryamlustberg.bsky.social shares two presentations during Education Session 4: Hormone Replacement Therapy in #BreastCancer Care. sabcs.org/events/educa... @sabcs.bsky.social

📌Starting #SABCS25 off with a discussion of the Advanced Breast Cancer (ABC) Global Decade Report 📈 🔸improved 5 year OS 26% ➡️33% 🔸improvement in QOL, but 79% report negative QOL 🔸access to care gaps have widened ✅ 10 goals 2025-2035 #bcsm @maryamlustberg.bsky.social

LBCA was proud to sponsor the special session on lobular breast cancer at SABCS! #ILC #ILCawareness #lobularbreastcancer #SABCS25

Partners in Progress: This #SABCS25 Plenary Lecture will showcase how patients and advocates have expanded their roles in every stage of breast cancer research—including clinical trial design. Learn more in SABCS Meeting News: buff.ly/yKwCDRx

Leif Ellisen, MD, PhD, will moderate a Translational Workshop on advances in spatial omics at #SABCS25. Read a preview in SABCS Meeting News: buff.ly/swYtzxh

#breastcanceractionmonth #bcsm #bcam #diagnostic #supplemental #breast #imaging #healthequity #healthdisparities #blackbreastcancer #breastcancer #advocacy @susangkomen.bsky.social @acscan.bsky.social @novartis.bsky.social #nccn #palegblackcaucus

We're happy to be supporting key events happening during this group meeting, including: --Take Action Symposium --Latin America Initiative Symposium --Geriatric Assessment Workshop --kickoff sessions, trainings, and more! #SWOGonc As always, *thank you* to our donors who make so much possible 🙏

Powerful and Emotional #ProtectCancerCures #MCED @acscan.bsky.social #cancer #research #breastcancer #bcsm #calltoaction #advocacy ACS CAN PA

Excited for #cancerlobbyday with @acscan.bsky.social ACS CAN PA #cancer #bcsm #breastcancer #research #advocacy #clinialtrials

Awesome start of the @acscan.bsky.social Leadership Summit & Lobby Day 2025 looking forward to spending the rest of the week with great advocates from across the country!! #canceradvocacy #LightsofHope #breastcancer #bcsm #cancerlobbyday #cancer #advocates

Excellent conference! Highly recommend! Total Health’s 2025 ASCO Direct @swog.org @ascocancer.bsky.social @oncoalert.bsky.social #breastcancer #cancer #clinicaltrials #bcsm #ASCODirect25

S2212 SCARLET is a randomized @swog.org ph 3 trial of treatment de-escalation in early-stage #triplenegative #breastcancer, comparing neoadjuvant immunotherapy + chemo w/wo anthracyclines. #TNBC SWOG.org/clinical-trials/S2212 PI: Priyanka Sharma, MD @ibcresearch1.bsky.social @raalbany.bsky.social

Wonderful to be nominated! Please vote for Black Cancer Collaborative. www.linkedin.com/posts/healio... www.surveymonkey.com/r/HealioInno...

Reflecting on last weekend’s BaddieCon2025 in Atlanta, I am filled with pride and gratitude. Looking out into the audience and seeing all those beautiful faces of Black/Women of Color, where we did not have to shrink ourselves, was truly empowering! Thank you For The Breast of Us! #blackbreastcancer

Nice birthday present! Thank you for the honor! For The Breast of Us!!💜💜

Please share! voices.cancer.org @acscan.bsky.social

#NBCContheHill @nbccstopbc.bsky.social #breastcancer #advocacy #stageivbreastcancer #worldcancerday

ABC Philadelphia spoke to NBCC President Fran Visco about her work with NBCC to end breast cancer and what it means to win the Presidential Citizens Medal. Watch and read more here! 6abc.com/post/philade...

“What I want you to know is that we are not going to change what we do or how we do https://it.The world doesn’t need NBCC to do what everyone else is doing,” Fran Visco said. @nbccstopbc.bsky.social https://cancerletter.com/white-house/20250110_3

By offering world-class, targeted training in breast cancer science and public policy, NBCC readies breast cancer advocates to become agents of action and change in the mission to end breast cancer. stopbreastcancer.org/focus/educat...

Analysis of RxPONDER trial data by @yabdoumd.bsky.social, et al, in JNCI highlights persistent racial disparities in #breastcancer outcomes. doi.org/10.1093/jnci... #bcsm #HealthDisparities @unclineberger.bsky.social @ibcresearch1.bsky.social @raalbany.bsky.social @jrgralow.bsky.social

@swog.org #clinicaltrial #blackbreastcancer #tnbc #breastcancer #bcsm #oncoalert

Watch the recording from our recent webinar: Managing Menopause After Breast Cancer: Weight, Hot Flashes in Rehabilitation Speakers: @maryamlustberg.bsky.social, @raalbany.bsky.social, and Dr. Amy Comander vimeo.com/1041139015 #SuppOnc #bcsm Webinar supported by Nestlé Health Science

@cancercaremascc.bsky.social webinar today with Amy Comander and @raalbany.bsky.social #bcsm #supponc

URGENT: Congress has just days to pass a year-end package, which includes a bill to make multi-cancer #EarlyDetection tests more available. Last call➡️Send a message to your members of Congress right now urging them to prioritize the fight against cancer.

Pinging: @fernandoonco.bsky.social @maryamlustberg.bsky.social @tmprowell.bsky.social @raalbany.bsky.social @drsgraff.bsky.social @itsnotpink.bsky.social @stage4kelly.bsky.social @guinadermarta.bsky.social @darcyburbage.bsky.social @drgattimays.bsky.social @drteplinsky.bsky.social ‪

Imlunestrant + abemaciclib likely to become a new 2L treatment option for HR+/HER2- Metastatic breast cancer @ptarantinomd.bsky.social @breastcancerdoc.bsky.social oncodaily.com/blog/imlunes... #Cancer #Imlunestrant #OncoDaily #Oncology #Medicine #Health

Here’s another impactful session about health disparities #systemic #structuralracism #global #healthequityforall #bcsm #oncoalert #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social @swog.org @yabdoumd.bsky.social

At #SABCS24 LBA session - @LoiblSibylle on the PADMA trial comparing 1st line ET + Palbo vs Standard Mono-CT in High Risk HER2-/HR+ metastatic BC and indication for CT ⬆️TTF and PFS w/palbo+ET Reassuring data supporting 1st line CDK4/6i+ET as SoC @oncoalert.bsky.social

Omission of Axillary surgery continues to build momentum Here in pts w/ cN0 T1-2 invasive breast cancer—omission is noninferior to SLNB w 6 years med f/u Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial www.nejm.org/doi/full/10.... #SABCS24 @oncoalert.bsky.social @nejm.org

Final primary results of the #INSEMA trial presented at #SABCS24: de-escalating surgical interventions for patients with early invasive #BreastCancer undergoing breast-conserving surgery. Download the presentation: www.gbg.de/en/news/deta... Read full @nejm.org paper: www.nejm.org/doi/full/10....

Very impactful session @sabcs.bsky.social #bcsm #healthequity #disparities #SABCS24 #oncoalert @oncoalert.bsky.social

Faculty🚨 @erikahamilton9.bsky.social @hoperugo.bsky.social @drsgraff.bsky.social @maryamlustberg.bsky.social @raalbany.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @stolaney1.bsky.social @fernandoonco.bsky.social @coffeemommy.bsky.social @stoverlab.bsky.social

Don’t forget to register for our webinar on Dec 19: Managing Menopause After Breast Cancer: Weight, Hot Flashes in Rehabilitation Learn more or register: us02web.zoom.us/webinar/regi... Webinar supported by Nestlé Health Science  #SuppOnc #bcsm @maryamlustberg.bsky.social @raalbany.bsky.social

Welcome to #SABCS24 Faculty🚨 @erikahamilton9.bsky.social @hoperugo.bsky.social @drsgraff.bsky.social @maryamlustberg.bsky.social @raalbany.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @stolaney1.bsky.social @fernandoonco.bsky.social @coffeemommy.bsky.social

It's our first #GivingTuesday as a non-profit 🎉 At Advocates for Collaborative Education, we are on a mission to unite and empower advocates through pan-cancer collaborations, advocacy education, and the sharing of best practices. If you're so inclined, we would love your support! #PatientAdvocacy

Our #TranslationalMedicine Link of the Week, chosen by SWOG's Lee Ellis, MD, and Jimmy Rae, PhD: "Pharmacological and Biological Targeting of FGFR1 in Cancer" in _Current Issues in Molecular Biology_ doi.org/10.3390/cimb...